Skip to Main Content

Paper Details

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial.
Eur Heart J Cardiovasc Pharmacother
6
2022
Author NameAffiliation
Renato D LopesDuke Clinical Research Institute
John H AlexanderDuke Clinical Research Institute
  • 1 - 2

Datasets

Release 1.2